PetMed Express, Inc. PETS
1.03 USD -0.04 (-3.43%)
Nov 12, 2026, 11:30 AM EST
1.02 Day range 1.08
1.02 52-week range 4.10
- YTD
- -67.86%
- 1 year
- -64.53%
News
zacks.com PetMed (PETS) Reports Q2 Loss, Lags Revenue Estimates PetMed (PETS) came out with a quarterly loss of $0.31 per share versus the Zacks Consensus Estimate of a loss of $0.11. This compares to a loss of $0.41 per share a year ago.
seekingalpha.com PetMed Express, Inc. (PETS) Q2 2027 Earnings Call Prepared Remarks Transcript PetMed Express, Inc. (PETS) Q2 2027 Earnings Call Prepared Remarks Transcript
benzinga.com PetMed Express Q2 2027 Earnings Call Transcript PetMed Express (NASDAQ:PETS) reported second-quarter financial results on Tuesday. The transcript from the company’s second-quarter earnings call has been provided below.This transcript is brought to…
benzinga.com PetMed Express Q2 EPS $(0.31) Misses $(0.11) Estimate, Sales $35.770M Beat $7.222M Estimate PetMed Express (NASDAQ:PETS) reported quarterly losses of $(0.31) per share which missed the analyst consensus estimate of $(0.11) by 181.82 percent. This is a 24.39 percent increase over losses of…
globenewswire.com PetMeds® Announces Second Quarter Financial Results DELRAY BEACH, Fla., Nov. 10, 2026 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ: PETS) today announced its financial results for its second quarter…
benzinga.com PetMeds Partners With Pet Supermarket To Offer Pet Prescription Medications, Preventatives And Health Products To Pet Parents Across Pet Supermarket’s Retail Stores And Digital Platforms PetMed Express, Inc., dba PetMeds and parent company of PetCareRx (NASDAQ:PETS), today announced a new partnership with Pet Supermarket to offer pet prescription medications, preventatives and health…
globenewswire.com PetMeds Announces Strategic Partnership with Pet Supermarket to Expand Pharmacy Offering Across Retail and Digital Channels DELRAY BEACH, Fla., Nov. 09, 2026 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx (Nasdaq: PETS), today announced a new partnership with Pet Supermarket to offer…
benzinga.com Morgan Stanley Maintains Underweight on PetMed Express, Lowers Price Target to $1.4 Morgan Stanley analyst Erin Wright maintains PetMed Express (NASDAQ:PETS) with a Underweight and lowers the price target from $2.15 to $1.4.
benzinga.com 12 Consumer Discretionary Stocks Moving In Monday's After-Market Session Gainers GoPro (NASDAQ:GPRO) shares rose 21.0% to $1.06 during Monday's after-market session. The company's market cap stands at $110.6 million. Golden Sun Technology (NASDAQ:GSUN) shares rose 13.1%…
benzinga.com Full Transcript: PetMed Express Q1 2027 Earnings Call On Thursday, PetMed Express (NASDAQ:PETS) discussed first-quarter financial results during its earnings call. The full transcript is provided below. Benzinga APIs provide real-time access to earnings…
benzinga.com PetMed Express Q1 EPS $(0.28) Misses $0.12 Estimate, Sales $41.015M Beat $10.336M Estimate PetMed Express (NASDAQ:PETS) reported quarterly losses of $(0.28) per share which missed the analyst consensus estimate of $0.12 by 333.33 percent. This is a 83.03 percent increase over losses of…
benzinga.com PetMed Express Board Confirms Proposed $3/Share Acquisition Offer From SilverCape Investments PetMed Express, Inc. ("PetMeds" or the "Company") (NASDAQ:PETS) today confirmed that its Board of Directors (the "Board") has received an unsolicited, non-binding, and conditional proposal from
benzinga.com Activist Investor Slams PetMed Board For 'Stunning Destruction' Of Shareholder Value PetMed Express ($PETS) stock surges after SilverCape Investments proposes a $3/share cash buyout, representing a 70% premium.
benzinga.com SilverCape Investments Revises Acquisition Proposal For PetMed Express To $3.00 Per Share In Cash With No Financing Contingency; Seeks PETS Board Engagement The proposed purchase price represents a premium of approximately 70% to PetMed’s closing share price of $1.76 on June 26, 2026.In its letter to the Board, SilverCape outlines its belief that:Based…
benzinga.com 12 Consumer Discretionary Stocks Moving In Wednesday's Intraday Session - benzinga.com PetMed Express Reports Q4 2026 Results: Full Earnings Call Transcript
- benzinga.com PetMed Express Board Rejects Acquisition Proposals; Company To Remain Independent; Says Remains Open To Considering Any Inbound Indications Of Interest With Respect To Potential Deal That May Be Received In Future In December 2025, the Company received two unsolicited, non-binding preliminary proposals from two separate third parties to acquire all of the outstanding shares of Common Stock of the Company at…
- benzinga.com 12 Consumer Discretionary Stocks Moving In Wednesday's After-Market Session
- benzinga.com 12 Consumer Discretionary Stocks Moving In Wednesday's After-Market Session
- benzinga.com 12 Consumer Discretionary Stocks Moving In Tuesday's Pre-Market Session
benzinga.com From Christmas Treats To GPS Collars: How Americans Are Still Spending On Pets And What It Means For Pet Care Stocks In 2026 Pet spending stayed resilient in 2025 despite inflation. See which pet care stocks Wall Street is watching heading into 2026.
benzinga.com Cardone Ventures Offers Full Buyout Of PetMed Express, Stock Soars PetMed Express shares rose again after Cardone Ventures floated a nonbinding all-cash buyout proposal that reignited takeover speculation.
benzinga.com PetMed Express Receives Proposal From Cardone Ventures To Acquire The Co For ~$89M, Or $4.25 Per Share Cardone Ventures, backed by billionaire investor, Grant Cardone and his business partners Brandon and Natalie Dawson, today announced that it has submitted an unsolicited, non-binding proposal to…- benzinga.com PetMed Express Board Approves One-Year Shareholder Rights Plan Through Dec. 2, 2026 PetMed Express, Inc., d/b/a PetMeds and parent company of PetCareRx, (Nasdaq: PETS) (the "Company"), today announced that its Board of Directors (the "Board") has unanimously approved an amendment to…
benzinga.com 12 Consumer Discretionary Stocks Moving In Thursday's Intraday Session - benzinga.com PetMed Express Receives Nasdaq Delinquency Notification PetMed Express, Inc. d/b/a PetMeds and parent company of PetCareRx, (Nasdaq: PETS) (the "Company"), today announced preliminary second quarter fiscal year 2026 results and filed a Form 12b-25,…
benzinga.com 12 Consumer Discretionary Stocks Moving In Wednesday's Pre-Market Session 
benzinga.com PetMed Express Announces That Its CEO Sandra Campos And CFO Robyn D'Elia Have Resigned. Leslie C.G. Campbell Has Been Appointed Interim CEO And Douglas Krulik Has Been Appointed Interim Principal Financial Officer PetMed Express, Inc. (the "Company") dba PetMeds and parent company of PetCareRx (NASDAQ:PETS) today announced that its Chief Executive Officer, Sandra Campos, and Chief Financial Officer, Robyn…- benzinga.com 12 Consumer Discretionary Stocks Moving In Monday's After-Market Session
- benzinga.com 12 Consumer Discretionary Stocks Moving In Monday's After-Market Session
- benzinga.com 12 Consumer Discretionary Stocks Moving In Monday's After-Market Session
- benzinga.com PetMed Express Receives Notification Of Deficiency From Nasdaq PetMed Express, Inc. ("PetMeds®") (NASDAQ:PETS) received on July 2, 2025, an expected notice (the "Notice") from The Nasdaq Stock Market LLC ("Nasdaq") indicating that, as a result of not having…
- benzinga.com 12 Consumer Discretionary Stocks Moving In Monday's After-Market Session
- benzinga.com PetMed Express Sees Q4 Net Sales Of $51.1M-$53.1M And Net Loss Of $9.9M-$10.4M; Sees FY25 Net Sales Of $231.6M-$233.6M With Net Loss Of $4.5M-$5.0M Preliminary Fourth Quarter and FY 2025 Results:For the fiscal fourth quarter ended March 31, 2025, net sales are estimated to range from $51.1 million to $53.1 million compared to $66.5 million in…
- benzinga.com Earnings Scheduled For June 16, 2025
- benzinga.com Earnings Preview: PetMed Express
- benzinga.com 12 Consumer Discretionary Stocks Moving In Wednesday's Pre-Market Session
benzinga.com 12 Consumer Discretionary Stocks Moving In Tuesday's After-Market Session - benzinga.com Earnings Scheduled For June 10, 2025
- benzinga.com What to Expect from PetMed Express's Earnings
- benzinga.com Silvercape Investments Says Intends To Engage In Discussions With PetMed Express' Management And/Or Co's Board; It May Also Discuss Possibility Of Nominating Person To Become Director Of PetMed Express The Reporting Persons have been an investor in the Issuer since February 2025 and hold the Common Stock for investment purposes. The Reporting Persons have previously reported their beneficial…
- benzinga.com Morgan Stanley Maintains Underweight on PetMed Express, Lowers Price Target to $3.2 Morgan Stanley analyst Erin Wright maintains PetMed Express (NASDAQ:PETS) with a Underweight and lowers the price target from $3.5 to $3.2.
- benzinga.com 12 Consumer Discretionary Stocks Moving In Tuesday's Pre-Market Session
- benzinga.com 12 Consumer Discretionary Stocks Moving In Tuesday's Pre-Market Session
- benzinga.com PetMed Express Q3 2025 GAAP EPS $(0.03) Misses $0.01 Estimate, Sales $53.000M Miss $59.600M Estimate PetMed Express (NASDAQ:PETS) reported quarterly losses of $(0.03) per share which missed the analyst consensus estimate of $0.01 by 400 percent. This is a 70 percent increase over losses of $(0.10)…
- benzinga.com Earnings Scheduled For February 10, 2025
- benzinga.com 10 Consumer Discretionary Stocks Whale Activity In Today's Session
- benzinga.com PetMeds Board Of Directors Has Adopted A Limited Duration Shareholder Rights Plan To Protect The Best Interests Of All PetMeds Shareholders, Effective Immediately And Will Expire On December 2, 2025 PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ:PETS) ("PetMeds" or the "Company"), today announced that its Board of Directors (the "Board") has adopted a limited duration…
- benzinga.com PetMed Express Q2 2025 GAAP EPS $0.11 Beats $(0.05) Estimate, Sales $59.570M Miss $66.000M Estimate PetMed Express (NASDAQ:PETS) reported quarterly earnings of $0.11 per share which beat the analyst consensus estimate of $(0.05) by 320 percent. This is a 266.67 percent increase over earnings of…
- benzinga.com Lake Street Downgrades PetMed Express to Hold, Lowers Price Target to $3.5 Lake Street analyst Ryan Meyers downgrades PetMed Express (NASDAQ:PETS) from Buy to Hold and lowers the price target from $7 to $3.5.